Why is Eli Lilly considered a good investment?

Due to its strong GLP-1 portfolio, pipeline progress, and 2026 acquisitions.

What sets Costco apart?

Its membership model and strong earnings growth.

How has Morgan Stanley performed recently?

It reported strong results with improved revenue from investment banking and wealth management.

Top Research Reports: Eli Lilly, Costco, and Morgan Stanley

Zacks issued a report highlighting three key stocks: Eli Lilly (LLY) driven by its GLP-1 portfolio, Costco (COST) for earnings growth, and Morgan Stanley (MS) for strong performance.

July 21, 2026

2 min read

Source: Zacks

According to a report by Zacks, three key stocks have been highlighted for investors: Eli Lilly (LLY), Costco (COST), and Morgan Stanley (MS).

Details

Eli Lilly (LLY)

Eli Lilly continues to grow thanks to its GLP-1 drug portfolio, pipeline progress, and acquisitions made in 2026. Despite pricing pressure and rising competition, the company remains well-positioned.

Costco (COST)

Costco continues to deliver strong earnings growth, supported by its membership-based business model and ability to maintain healthy margins.

Morgan Stanley (MS)

Morgan Stanley reported strong results in its latest earnings, with improved revenue from investment banking and wealth management.

Context

The report comes amid market volatility, as investors seek stocks with strong fundamentals. BlackRock (BLK) and Prologis (PLD) were also mentioned as stocks to watch.

What This Means for Investors

These stocks offer a mix of growth and stability, making them attractive for long-term investors. However, sector-specific risks should be considered.

Frequently Asked Questions

The report highlighted Eli Lilly (LLY), Costco (COST), and Morgan Stanley (MS) as top stocks.

Found this useful? Share it

This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.